# Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer

> **NCT01565772** · PHASE1 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 4 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** Proton Beam Radiation
- **DRUG:** Cisplatin
- **DRUG:** Etoposide

## Key facts

- **NCT ID:** NCT01565772
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2016-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01565772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01565772, "Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01565772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*